Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2014 Results
Date:8/7/2014

OTE REGARDING FORWARD-LOOKING STATEMENTSVarious statements in this release, including, but not limited to, the guidance provided under "2014 FINANCIAL GUIDANCE" above, are "forward-looking statements" under the securities laws. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "project," "target," "goal," "likely," "will," "would," and "could," or the negative of these terms and similar expressions or words, identify forward-looking statements.  Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties.  Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: Vanda's ability to successfully commercialize HETLIOZ® for the treatment of Non-24 in the U.S., uncertainty as to the market awareness of Non-24 and the market acceptance of HETLIOZ®, Vanda's dependence on third-party manufacturers to manufacture HETLIOZ® in sufficient quantities and quality, Vanda's limited sales and marketing infrastructure, the regulatory status of HETLIOZ® in Europe and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2013 which is on file with the SEC and available on the SEC's website at www.sec.gov and Vanda's quarterly report on Form 10-Q for the quarter ended June 30, 2014 to be filed with the SEC.  In addition to the risks described above and in Vanda's annual report on Form 10-K and quarterly reports on Form 10-Q, current reports on Form 8-K and other filings with the SEC, other unknown or unpredictable factors also could affect Vanda's results.  There can b
'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2013 Results
2. Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
3. Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
4. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
5. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
6. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
7. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
8. Vanda Pharmaceuticals, Inc. Sued by Investor
9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
10. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
11. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Latanoprost ... Developed by Pharmacia & Upjohn in 1995, ... effectively reduces intraocular pressure. As the first pressure- ... trade name of Xalatan) entered China ...
(Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ... it has completed the acquisition of leading OTC brands ... €200 million. The transaction is a clear demonstration of ... Company,s leading European distribution network spanning 36 countries.  ... C. Papa commented, "We are excited to complete ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5
... VIEW, Calif. , Feb. 16 Alexza Pharmaceuticals, Inc. (Nasdaq: ... on Thursday, February 18, 2010 from 9:00 a.m. - ... meeting will include presentations from: , Thomas King - ... PhD - SVP, Research and Development, Alexza Pharmaceuticals Michael Lesem ...
... , REDWOOD CITY, Calif. ... provider of information solutions for life science researchers, today announced ... metabolomics workflow support in the latest release of IPA® software. ... increasingly complex developments in the diagnosis, treatment, and etiology of ...
Cached Medicine Technology:Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4IPA Helps Researchers Utilize and Share Current Disease Knowledge Through New Dynamic Reporting Capability 2
(Date:8/28/2015)... ... , ... Saint Petersburg, FL —Pocket Protein™, a protein beverage ... gluten, lactose or caffeine in a convenient 2 oz. pouch that never needs ... Awards. , Five consumer packaged goods (CPG) products were selected by the SupplySide ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville ... military veterans leading in business. Mr. Troy Mizell, Chairman of the Board ... Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, through ...
(Date:8/28/2015)... , ... August 28, 2015 , ... Northridge dentists ... Zoom teeth whitening. For just $199, patients can currently receive a one hour treatment ... teeth whitening procedures, but it includes a number of unique features that can turn ...
(Date:8/28/2015)... ... ... The newest therapy to receive orphan drug status for the treatment of malignant ... educational website Surviving Mesothelioma. Click here to read their article on MTG-201. ... from the FDA, will now head into Phase I clinical trials to establish its ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... BOSTON July 1, 2008 A study by researchers ... prescribed dietary recommendations is associated with better glucose control in ... management has been focused around new medications and technologies," said ... published in the July issue of Diabetes Care . ...
... including polio,eradication, EVANSTON, Ill., July 1 Jonathan ... 1 as chair of The,Rotary Foundation of Rotary International, ... last remaining strongholds -- which include his,homeland., "I ... said Majiyagbe.,"It is abundantly clear to all of us ...
... Pittsburgh-based Foundation,Radiology Group (FRG) has signed ... and Knox County Hospital, Barbourville,KY, through which ... diagnostic,imaging professional services, effective July 1st., ... acute care 136-bed,hospital. It offers a wide ...
... In conjunction with,its second quarter 2008 earnings release (expected to ... CVD ) is pleased to invite you,to listen to its quarterly ... Thursday, July 31, 2008 at 9:00 a.m. ET., What: ... Presentation, When: ...
... School of Medicine have identified a potential new way ... DNA constructed to build antigens against flu, along with ... against various strains of the virus. This approach could ... could be easily and effectively dispensed in case of ...
... of certain malignancies , , TUESDAY, July 1 (HealthDay News) -- ... dimmer switch to stop a "cancer signal" from contributing to ... cure, and no one knows if they will even lead ... a pathway for scientists to follow as they determine which ...
Cached Medicine News:Health News:Dietary adherence associated with better glucose control in children with type 1 diabetes 2Health News:The Rotary Foundation's First African Trustee Chair Takes Office 2Health News:The Rotary Foundation's First African Trustee Chair Takes Office 3Health News:Foundation Radiology Group Signs Multi-Year Contracts for Diagnostic Services with Pineville Community and Knox County Hospitals 2Health News:Penn animal study identifies new DNA weapon against avian flu 2Health News:Penn animal study identifies new DNA weapon against avian flu 3Health News:Scientists Find Way to Dim Cancer Switch 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Select ... art, automated microbial detection system ... fluid and mycobacteria culturing. This ... data management or laboratory information ...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid One, a microbial identification system....
Medicine Products: